Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J, Bartha G, Harris J, Li C, Navarro FCP, Pyke RM, Hong M, Zhang Q, Ma S, Chen TX, Lai J, Udar N, Saldivar JS, Ayash E, Anderson J, Li J, Cui T, Le T, Chow R, Velasco RJ, Mallo C, Santiago R, Bruce RC, Goodman LJ, Chen Y, Norton D, Chen RO, Lyle JM.
Northcott J, et al. Among authors: bruce rc.
Oncotarget. 2024 Mar 14;15:200-218. doi: 10.18632/oncotarget.28565.
Oncotarget. 2024.
PMID: 38484152
Free PMC article.